Testing of herpes simplex virus for resistance to antiviral drugs

Virulence

Volumn 1, Issue 6, 2010, Pages 555-557

  Sauerbrei, Andreas ^a   Deinhardt, Stefanie ^a   Zell, Roland ^a   Wutzler, Peter ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Dna polymerase; Genotypic resistance; Herpes simplex virus; Phenotypic resistance; Thymidine kinase

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; CIDOFOVIR; DNA POLYMERASE; FOSCARNET; NUCLEOTIDE; PENCICLOVIR; THYMIDINE KINASE;

ARTICLE; DNA POLYMORPHISM; DNA SEQUENCE; ENZYME POLYMORPHISM; ENZYME SYNTHESIS; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; SEQUENCE ANALYSIS; VIRUS ISOLATION; VIRUS STRAIN;

HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 79251481093     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.1.6.13806     Document Type: Article

References (30)

1. Dolan A, Jamieson FE, Cunnigham C, Barnett BC, McGeogh DJ. The genome sequence of herpes simplex virus type 2. J Virol 1998; 72:2010-21.
2. Miller GG, Dummer JS. Herpes simplex and varicella- zoster viruses: Forgotten but not gone. Am J Transplant 2007; 7:741-7.
3. Morfin F, Thouvenout D. Herpes simplex virus resistance to antiviral drugs. J Clin Virol 2003; 26:29-37.
4. Larder BA, Darby G. Selection and characterization of acyclovir-resistant herpes simplex virus type 1 mutants inducing alterated DNA polymerase activities. Virology 1986; 146:262-71.
5. Coen DM, Kosz-Vnenchak M, Jacobson JG, Leib DA, Bogard CL, Schaffer PA, et al. Thymidine kinasenegative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc Natl Acad Sci USA 1989; 86:4736-40.
6. Dambrosi S, Martin M, Yim K, Miles B, Canas J, Sergerie Y, et al. Neurovirulence and latency of drugresistant clinical herpes simplex viruses in animal model. J Med Virol 2010; 82:1000-6.
7. Bacon TH, Levin MJ, Leary JJ, Sarisky RT, Sutton D. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Mcrobiol Rev 2003; 16:114-28.
8. Chakrabarti S, Pillay D, Ratcliffe D, Cane PA, Collingham KE, Milligan DW. Resistance to antiviral drugs in herpes simplex virus infections among allogenic stem cell transplant recipients: risk factors and prognostic significance. J Infect Dis 2000; 181:2055-8.
9. Frobert E, Cortay JC, Ooka T, Najioullah F, Thouvenot D, Lina B, et al. Genotypic detection of acyclovir-resistant HSV-1: Characterization of 67 ACV-sensitive and 14 ACV-resistant viruses. Antiviral Res 2008; 79:28-36.
10. Fyfe JA. Differential phosphorylation of (E)-5(2- bromovinyl)-2'-deoxyuridine monophosphate by thymidylate kinases from herpes simplex viruses types 1 and 2 and varicella-zoster virus. Mol Pharmacol 1982; 21:432-7.
11. Wassilew SW, Wutzler P. Brivudin Herpes Zoster Study Group. Oral brivudin in comparison with acyclovir for herpes zoster: A survey study on postherpetic neuralgia. Antviral Res 2003; 59:57-60.
12. Safrin S, Asseykeen T, Follansbee S, Mills J. Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data. J Infect Dis 1990; 161:1078-84.
13. Tan HH, Goh CL. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies. Am J Clin Dermatol 2006; 7:13-29.
14. Wyles DL, Patel A, Madinger N, Bessesen M, Krause PR, Weinberg A. Development of herpes simplex virus disease in patients who are receiving cidofovir. Clin Infect Dis 2005; 41:676-80.
15. Morfin F, Souillet G, Bilger K, Ooka T, Aymard M, Thouvenot D. Genetic characterization of thymidine kinase from acyclovir-resistant and -susceptible herpes simplex virus type 1 isolated from bone marrow transplant recipients. J Infect Dis 2000; 182:290-3.
16. Chiba A, Suzutani T, Sajo M, Koyano S, Azuma M. Analysis of nucleotide sequence variations in herpes simplex virus types 1 and 2, and varicella-zoster virus. Acta Virol 1998; 42:401-7.
17. McGeoch DJ, Dolan A, Donald S, Rixon FJ. Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. J Mol Biol 1985; 181:1-13.
18. McGeoch DJ, Moss HW, McNab D, Frame MC. DNA sequence and genetic content of the HindIII 1 region in the short unique component of the herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G, and evolutionary comparison. J Gen Virol 1987; 68:19-38.
19. Burrel S, Deback C, Agut H, Boutolleau D. Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals. Antimicrob Agents Chemother 2010; 54:4833-42.
20. Watson-Jones D, Wald A, Celum C, Lingappa J, Weiss HA, Changalucha J, et al. Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials. J Clin Microbiol 2010; 48:3496-503.
21. Chibo D, Druce J, Sasadeusz J, Birch C. Molecular analysis of clinical isolates of acyclovir resistant herpes simplex virus. Antiviral Res 2004; 61:83-91.
22. Gaudreau A, Hill E, Balfour HH Jr, Erice A, Boivin G. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J Infect Dis 1998; 178:297-303.
23. Sajo M, Suzutani T, De Clercq E, Niikura M, Maeda A, Morikawa S, Kurane I. Genotypic and phenotypic characterization of the thymidine kinase of ACVresistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain. Antiviral Res 2002; 56:253-62.
24. Stránská R, Schuurman R, Scholl DR, Jollick JA, Shaw CJ, Loef C, et al. ELVIRA HSV, a yield reduction assay for rapid herpes simplex virus susceptibility testing. Antimicrob Agents Chemother 2004; 48:2331-3.
25. Suzutani T, Sajo M, Nagamine M, Ogasawara M, Azuma M. Rapid phenotypic characterization method for herpes simplex virus and varicella-zoster virus thymidine kinase to screen for acyclovir-resistant viral infections. J Clin Microbiol 2000; 38:1839-44.
26. Balasubramaniam NK, Veerisetty V, Gentry GA. Herpesviral deoxythymidine kinases contain a site analogous to the phophoryl-binding arginine-rich region of porcine adenylate kinase; comparison of secondary structure predictions and conservation. J Gen Virol 1990; 71:2979-87.
27. Graham D, Larder BA, Inglis MM. Evidence that the 'active centre' of the herpes simplex virus thymidine kinase involves an interaction between three distinct regions of the polypeptide. J Gen Virol 1986; 67:753-8.
28. Sauerbrei A, Eichhorn U, Hottenrott G, Wutzler P. Virological diagnosis of herpes simplex encephalitis. J Clin Virol 2000; 17:31-6.
29. Nugier F, Colin JN, Aymard M, Langlois M. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a twoyear sensitivity screening survey. J Med Virol 1992; 36:1-12.
30. Frobert E, Thouvenot D, Lina B, Morfin F. Genotyping diagnosis of acyclovir-resistant herpes simplex virus. Pathol Biol (Paris) 2007; 55:504-11.